Expression of Cyclin D1 and Cyclin D3 in Cases of Non-Hodgkin's Lymphomas of B-Cell Lineage
| . | Cyclin D3 . | Cyclin D1 . |
|---|---|---|
| MCL | 0/26* | 23/26 (88.5%) |
| CLL | 12/12 (100.0%) | 0/12 |
| MALT | 9/11 (81.2%) | 0/11 |
| FCL | 17/20 (85.0%) | 0/20 |
| DLBL | 11/12 (91.7%) | 0/12 |
| . | Cyclin D3 . | Cyclin D1 . |
|---|---|---|
| MCL | 0/26* | 23/26 (88.5%) |
| CLL | 12/12 (100.0%) | 0/12 |
| MALT | 9/11 (81.2%) | 0/11 |
| FCL | 17/20 (85.0%) | 0/20 |
| DLBL | 11/12 (91.7%) | 0/12 |
Abbreviations: MCL, mantle cell lymphoma; CLL, chronic lymphocytic lymphoma; MALT, mucosa-associated lymphatic tissue; FCL, follicular cell lymphoma; DLBL, diffuse large B-cell lymphoma.
Seven cases showed a completely negative reaction; less than 5% of cells within the tumor cell infiltrate were positive in the remaining 19 cases.